Quest Capital Management’s Pfizer PFE Stock Holding History

Quest Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$591K	Sell	10,012 -960	-9%	-$47.6K	0.1%	132
2021 Q3	$472K	Sell	10,972 -1,591	-13%	-$70.5K	0.09%	144
2021 Q2	$492K	Buy	12,563 +2,165	+21%	+$84.2K	0.1%	136
2021 Q1	$377K	Sell	10,398 -665	-6%	-$23.6K	0.08%	161
2020 Q4	$407K	Sell	11,063 -1,524	-12%	-$55.9K	0.1%	131
2020 Q3	$438K	Sell	12,587 -204	-2%	-$7.15K	0.12%	105
2020 Q2	$397K	Sell	12,791 -29,916	-70%	-$1.02M	0.12%	114
2020 Q1	$1.32M	Buy	42,707 +5,096	+14%	+$174K	0.45%	33
2019 Q4	$1.4M	Sell	37,611 -3,051	-8%	-$109K	0.33%	40
2019 Q3	$1.39M	Buy	40,662 +4,293	+12%	+$156K	0.34%	43
2019 Q2	$1.5M	Sell	36,369 -15,254	-30%	-$606K	0.38%	37
2019 Q1	$2.08M	Buy	51,623 +16,789	+48%	+$672K	0.52%	27
2018 Q4	$1.44M	Buy	+34,834	New	+$1.45M	0.42%	35

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Quest Capital Management's PFE Position: Q4 2021 in Review

Quest Capital Management reduced its Pfizer (PFE) stake by 8.7% in Q4 2021, selling an estimated $47.6K and leaving 10,012 shares worth $591K. The position accounts for 0.1% of the portfolio, ranked #132.

Quest Capital Management first reported a position in PFE in Q4 2018 and has held it in 13 quarters since. The position peaked at $2.08M in Q1 2019. 3,262 funds tracked by Wall St. Rank hold PFE as of Q4 2021.

Quest Capital Management held 10,012 shares of Pfizer worth $591K as of Q4 2021.
Quest Capital Management sold 960 Pfizer shares in Q4 2021, an estimated $47.6K.
Pfizer made up 0.1% of Quest Capital Management's portfolio in Q4 2021, its #132 holding.
Quest Capital Management first reported a position in Pfizer in Q4 2018 and has held it in 13 quarters since.
Quest Capital Management's Pfizer position peaked at $2.08M in Q1 2019.
3,262 funds tracked by Wall St. Rank held Pfizer as of Q4 2021.

Based on Quest Capital Management's 13F filing for Q4 2021, filed 31 Jan 2022.